← 10x Genomics, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.1m |
$146.3m
+105.83%
|
$245.9m
+68.06%
|
$298.8m
+21.53%
|
$490.5m
+64.13%
|
$516.4m
+5.28%
|
$618.7m
+19.81%
|
$610.8m
-1.28%
|
$642.8m
+5.25%
|
$616.9m
-4.03%
|
|
| Cost of products and services revenue | $10.6m |
$28.7m
+171.41%
|
$61.0m
+112.95%
|
$58.5m
-4.20%
|
$74.1m
+26.72%
|
$120.4m
+62.48%
|
$209.4m
+73.95%
|
$196.3m
-6.26%
|
$198.9m
+1.34%
|
— | |
| Gross profit | $60.5m |
$117.7m
+94.39%
|
$184.9m
+57.12%
|
$240.4m
+30.03%
|
$416.4m
+73.23%
|
$396.0m
-4.89%
|
$409.3m
+3.36%
|
$414.5m
+1.26%
|
$443.9m
+7.09%
|
$432.0m
-2.67%
|
|
| Research and development | $32.2m | $47.5m | $83.1m | $123.4m | $211.8m | $265.7m | $270.3m | $264.7m | $238.6m | $226.8m | |
| In-process research and development | — | $62.4m | $0 | $447.5m | $0 | $0 | $61.0m | $0 | $0 | — | |
| Selling, general and administrative | $46.7m | $87.9m | $130.8m | $202.3m | $257.6m | $298.3m | $343.3m | $344.3m | $316.1m | $297.0m | |
| Total operating expenses | $78.9m | $228.4m | $215.4m | $774.5m | $468.7m | $564.0m | $674.6m | $609.0m | $504.9m | $523.8m | |
| Loss from operations | ($18.4m) |
($110.8m)
-502.80%
|
($30.6m)
+72.40%
|
($534.1m)
-1647.10%
|
($52.3m)
+90.22%
|
($167.9m)
-221.41%
|
($265.3m)
-57.99%
|
($194.6m)
+26.67%
|
($61.0m)
+68.65%
|
— | |
| Interest expense | ($811k) | ($2.4m) | ($3.1m) | ($1.7m) | ($866k) | ($476k) | ($33k) | ($4k) | $0 | ($3k) | |
| Interest income | $308k | $1.0m | $2.8m | $1.5m | $206k | $6.6m | $16.9m | $18.4m | $20.0m | $21.9m | |
| Other income (expense), net | $137k | ($249k) | ($186k) | $1.3m | ($802k) | ($198k) | ($307k) | ($1.6m) | $1.0m | ($5.0m) | |
| Total other income | ($366k) | ($1.6m) | ($460k) | ($334k) | ($1.5m) | $6.0m | $16.6m | $16.9m | $21.1m | — | |
| Loss before provision for income taxes | ($18.7m) | ($112.4m) | ($31.0m) | ($534.5m) | ($53.7m) | ($162.0m) | ($248.8m) | ($177.7m) | ($39.9m) | — | |
| Provision for income taxes | $21k | $87k | $218k | $8.3m | $4.5m | $4.0m | $6.3m | $4.9m | $3.6m | — | |
| Net loss | ($18.8m) | ($112.5m) | ($31.3m) | ($542.7m) | ($58.2m) | ($166.0m) | ($255.1m) | ($182.6m) | ($43.5m) | — | |
| Net loss per share, basic (in dollars per share) | — | — | ($1) | ($5) | ($1) | ($1) | ($2) | ($2) | ($0) | — | |
| Net loss per share, diluted (in dollars per share) | — | — | ($1) | ($5) | ($1) | ($1) | ($2) | ($2) | ($0) | — | |
| Weighted-average shares used to compute net loss per share, basic (in shares) | — | — | ($1) | ($5) | ($1) | ($1) | ($2) | ($2) | ($0) | — | |
| Weighted-average shares used to compute net loss per share, diluted (in shares) | — | — | ($1) | ($5) | ($1) | ($1) | ($2) | ($2) | ($0) | — | |
| Gain on settlement | — | — | — | — | — | — | $0 | $0 | ($49.9m) | — |